EVs derived from lymphomas increase CTLA4 expression on CD8+ T cells, converting them into regulatory CD8+ T cells that perform immunosuppressive functions and secrete the inhibitory cytokines IL10 and TGF-β98. Here, CD8A is linked to lymphoma.